Status:
UNKNOWN
NeuroGlove Anxiety and Depression Study
Lead Sponsor:
NeuroGlove LLC
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This is a prospective, homebased, interventional clinical study containing 10 subjects who will be enrolled. Approximately 10 (10) subjects with active anxiety and depression symptoms will receive tre...
Detailed Description
This is a prospective, homebased, interventional clinical study containing 10 subjects who will be enrolled. Approximately 10 (10) subjects with active anxiety and depression symptoms will receive tre...
Eligibility Criteria
Inclusion
- Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
- Men and women ≥18 and \<85 years of age.
- Carry an active diagnosis of anxiety and/or depression.
- Suffer from anxiety and/or depression symptoms that impact subject's daily activities and quality of life.
Exclusion
- Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
- The subject lacks the ability to comprehend or following instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
- Currently participating in another interventional clinical trial. (Observational clinical trial participation is allowed for study enrollment.)
Key Trial Info
Start Date :
September 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06065787
Start Date
September 27 2023
End Date
November 1 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NeuroGlove
Minneapolis, Minnesota, United States, 55416